1. Increases in NMR visible lipid and glycerophosphocholine during phenylbutyrate-induced apoptosis in human prostate cancer cells;Milkevitch;Biochimica Biophysica Acta.,2005
2. Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate;Samid;J. Clin. Invest.,1993
3. Lovastatin enhances phenylbutyrate-induced MR-visible glycerophosphocholine but not apoptosis in DU145 prostate cells;Milkevitch;Biochimica Biophysica Acta.,2007
4. A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies;Gilbert;Clin. Cancer Res.,2001
5. Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia;Gore;Clin. Cancer Res.,2002